| Original language | English |
|---|---|
| Pages (from-to) | 328-330 |
| Number of pages | 3 |
| Journal | Journal of Antibiotics |
| Volume | 70 |
| Issue number | 3 |
| DOIs |
|
| Publication status | Published - 2017 Mar 1 |
Fingerprint
Therapeutics
arabilin
ASJC Scopus subject areas
- Pharmacology
- Drug Discovery
Cite this
Fujimaki, T., Saito, S., & Imoto, M. (2017). Arabilin overcomes resistance to AR-targeted therapy. Journal of Antibiotics, 70(3), 328-330. https://doi.org/10.1038/ja.2016.162
Arabilin overcomes resistance to AR-targeted therapy. / Fujimaki, Takahiro; Saito, Shun; Imoto, Masaya.
In: Journal of Antibiotics, Vol. 70, No. 3, 01.03.2017, p. 328-330.Research output: Contribution to journal › Comment/debate
Fujimaki, T, Saito, S & Imoto, M 2017, 'Arabilin overcomes resistance to AR-targeted therapy', Journal of Antibiotics, vol. 70, no. 3, pp. 328-330. https://doi.org/10.1038/ja.2016.162
Fujimaki T, Saito S, Imoto M. Arabilin overcomes resistance to AR-targeted therapy. Journal of Antibiotics. 2017 Mar 1;70(3):328-330. https://doi.org/10.1038/ja.2016.162
@article{e5be8e457a33457a94739ba3817b7dce,
title = "Arabilin overcomes resistance to AR-targeted therapy",
author = "Takahiro Fujimaki and Shun Saito and Masaya Imoto",
year = "2017",
month = "3",
day = "1",
doi = "10.1038/ja.2016.162",
language = "English",
volume = "70",
pages = "328--330",
journal = "Journal of Antibiotics",
issn = "0021-8820",
publisher = "Japan Antibiotics Research Association",
number = "3",
}
TY - JOUR
T1 - Arabilin overcomes resistance to AR-targeted therapy
AU - Fujimaki, Takahiro
AU - Saito, Shun
AU - Imoto, Masaya
PY - 2017/3/1
Y1 - 2017/3/1
UR - http://www.scopus.com/inward/record.url?scp=85014161200&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85014161200&partnerID=8YFLogxK
U2 - 10.1038/ja.2016.162
DO - 10.1038/ja.2016.162
M3 - Comment/debate
C2 - 28074047
AN - SCOPUS:85014161200
VL - 70
SP - 328
EP - 330
JO - Journal of Antibiotics
JF - Journal of Antibiotics
SN - 0021-8820
IS - 3
ER -